Nuwellis (NUWE) EBIT Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39,575.00 |
| Dec 31, 2025 | 2,087.00 |
| Sep 30, 2025 | 4,681.00 |
| Jun 30, 2025 | -775.00 |
| Mar 31, 2025 | -5,791.00 |
| Dec 31, 2024 | -3,808.00 |
| Sep 30, 2024 | 4,102.00 |
| Jun 30, 2024 | 14,999.00 |
| Mar 31, 2024 | -11,489.00 |
| Dec 31, 2023 | -967.00 |
| Sep 30, 2023 | 11,085.00 |
| Jun 30, 2023 | 7,840.00 |
| Mar 31, 2023 | -73,039.00 |
| Dec 31, 2022 | 59,979.00 |
| Sep 30, 2022 | 452.00 |
| Jun 30, 2022 | 3,493.00 |
| Mar 31, 2022 | 3,448.00 |
| Dec 31, 2021 | 1,961.00 |
| Sep 30, 2021 | -9,494.00 |
| Jun 30, 2021 | 8,362.00 |
| Mar 31, 2021 | -73,287.00 |
| Dec 31, 2020 | 68,439.00 |
| Sep 30, 2020 | -1,317.00 |
| Jun 30, 2020 | 6,977.00 |
| Mar 31, 2020 | 4,505.00 |
| Dec 31, 2019 | 3,475.00 |
| Sep 30, 2019 | -9,594.00 |
| Jun 30, 2019 | 12,485.00 |
| Mar 31, 2019 | -10,517.00 |
| Dec 31, 2018 | 2,809.00 |
| Sep 30, 2018 | 6,844.00 |
| Jun 30, 2018 | 3,961.00 |
| Mar 31, 2018 | 43,958.00 |
| Dec 31, 2017 | -56,028.00 |
| Sep 30, 2017 | -993.00 |
| Jun 30, 2017 | -3,308.00 |
| Mar 31, 2017 | -122,278.00 |
| Dec 31, 2016 | 171,469.00 |
| Mar 31, 2015 | -1.77 Mn |
| Dec 31, 2014 | 1.62 Mn |